Polar Capital Holdings PLC Immunocore Holdings PLC Transaction History
Polar Capital Holdings PLC
- $16.3 Billion
- Q4 2024
A detailed history of Polar Capital Holdings PLC transactions in Immunocore Holdings PLC stock. As of the latest transaction made, Polar Capital Holdings PLC holds 114,023 shares of IMCR stock, worth $3.38 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
114,023
Previous 501,755
77.28%
Holding current value
$3.38 Million
Previous $15.6 Million
78.47%
% of portfolio
0.02%
Previous 0.1%
Shares
7 transactions
Others Institutions Holding IMCR
# of Institutions
124Shares Held
42.5MCall Options Held
79.9KPut Options Held
46.2K-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.7MShares$198 Million0.12% of portfolio
-
Wellington Management Group LLP Boston, MA6.62MShares$196 Million0.04% of portfolio
-
Rtw Investments, LP New York, NY4.87MShares$144 Million2.34% of portfolio
-
Primecap Management CO Pasadena, CA2.67MShares$79 Million0.06% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.19MShares$64.8 Million0.01% of portfolio
About Immunocore Holdings plc
- Ticker IMCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,897,100
- Market Cap $1.3B
- Description
- Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...